Show simple item record

dc.contributor.authorTatton-Brown, K
dc.contributor.authorLoveday, C
dc.contributor.authorYost, S
dc.contributor.authorClarke, M
dc.contributor.authorRamsay, E
dc.contributor.authorZachariou, A
dc.contributor.authorElliott, A
dc.contributor.authorWylie, H
dc.contributor.authorArdissone, A
dc.contributor.authorRittinger, O
dc.contributor.authorStewart, F
dc.contributor.authorTemple, IK
dc.contributor.authorCole, T
dc.contributor.authorChildhood Overgrowth Collaboration,
dc.contributor.authorMahamdallie, S
dc.contributor.authorSeal, S
dc.contributor.authorRuark, E
dc.contributor.authorRahman, N
dc.date.accessioned2017-11-01T15:16:50Z
dc.date.issued2017-05-04
dc.identifier.citationAmerican journal of human genetics, 2017, 100 (5), pp. 725 - 736
dc.identifier.issn0002-9297
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/891
dc.identifier.eissn1537-6605
dc.identifier.doi10.1016/j.ajhg.2017.03.010
dc.description.abstractTo explore the genetic architecture of human overgrowth syndromes and human growth control, we performed experimental and bioinformatic analyses of 710 individuals with overgrowth (height and/or head circumference ≥+2 SD) and intellectual disability (OGID). We identified a causal mutation in 1 of 14 genes in 50% (353/710). This includes HIST1H1E, encoding histone H1.4, which has not been associated with a developmental disorder previously. The pathogenic HIST1H1E mutations are predicted to result in a product that is less effective in neutralizing negatively charged linker DNA because it has a reduced net charge, and in DNA binding and protein-protein interactions because key residues are truncated. Functional network analyses demonstrated that epigenetic regulation is a prominent biological process dysregulated in individuals with OGID. Mutations in six epigenetic regulation genes-NSD1, EZH2, DNMT3A, CHD8, HIST1H1E, and EED-accounted for 44% of individuals (311/710). There was significant overlap between the 14 genes involved in OGID and 611 genes in regions identified in GWASs to be associated with height (p = 6.84 × 10-8), suggesting that a common variation impacting function of genes involved in OGID influences height at a population level. Increased cellular growth is a hallmark of cancer and there was striking overlap between the genes involved in OGID and 260 somatically mutated cancer driver genes (p = 1.75 × 10-14). However, the mutation spectra of genes involved in OGID and cancer differ, suggesting complex genotype-phenotype relationships. These data reveal insights into the genetic control of human growth and demonstrate that exome sequencing in OGID has a high diagnostic yield.
dc.formatPrint
dc.format.extent725 - 736
dc.languageeng
dc.language.isoeng
dc.publisherCELL PRESS
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectChildhood Overgrowth Collaboration
dc.subjectHumans
dc.subjectNeoplasms
dc.subjectIntracellular Signaling Peptides and Proteins
dc.subjectDNA-Binding Proteins
dc.subjectNuclear Proteins
dc.subjectHistones
dc.subjectTranscription Factors
dc.subjectSequence Analysis, DNA
dc.subjectDevelopmental Disabilities
dc.subjectGene Expression Regulation
dc.subjectEpigenesis, Genetic
dc.subjectAmino Acid Sequence
dc.subjectLinkage Disequilibrium
dc.subjectMutation
dc.subjectAdolescent
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectInfant
dc.subjectFemale
dc.subjectMale
dc.subjectGenome-Wide Association Study
dc.subjectGenetic Loci
dc.subjectIntellectual Disability
dc.subjectEnhancer of Zeste Homolog 2 Protein
dc.subjectDNA (Cytosine-5-)-Methyltransferases
dc.subjectHistone Methyltransferases
dc.titleMutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability.
dc.typeJournal Article
dcterms.dateAccepted2017-03-24
rioxxterms.versionofrecord10.1016/j.ajhg.2017.03.010
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2017-05
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfAmerican journal of human genetics
pubs.issue5
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Genetic Susceptibility
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Genetic Susceptibility
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Genetic Susceptibility
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Genetic Susceptibility
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume100
pubs.embargo.termsNo embargo
icr.researchteamGenetic Susceptibility
dc.contributor.icrauthorClarke, Matthew


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0